Neuronetics Inc. (STIM)
Neuronetics Statistics
Share Statistics
Neuronetics has 63.68M shares outstanding. The number of shares has increased by 7.77% in one year.
| Shares Outstanding | 63.68M |
| Shares Change (YoY) | 7.77% |
| Shares Change (QoQ) | 5.84% |
| Owned by Institutions (%) | 24.83% |
| Shares Floating | 13.6M |
| Failed to Deliver (FTD) Shares | 9.63K |
| FTD / Avg. Volume | 0.61% |
Short Selling Information
The latest short interest is 735.04K, so 2.29% of the outstanding shares have been sold short.
| Short Interest | 735.04K |
| Short % of Shares Out | 2.29% |
| Short % of Float | 4.7% |
| Short Ratio (days to cover) | 4.05 |
Valuation Ratios
The PE ratio is -1.18 and the forward PE ratio is -4.28. Neuronetics's PEG ratio is -0.04.
| PE Ratio | -1.18 |
| Forward PE | -4.28 |
| PS Ratio | 0.68 |
| Forward PS | 1.3 |
| PB Ratio | 0 |
| P/FCF Ratio | -1.57 |
| PEG Ratio | -0.04 |
Enterprise Valuation
Neuronetics Inc. has an Enterprise Value (EV) of 85.91M.
| EV / Earnings | -1.99 |
| EV / Sales | 1.15 |
| EV / EBITDA | -2.52 |
| EV / EBIT | -2.52 |
| EV / FCF | -2.65 |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -4.67 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is -35.21%.
| Return on Equity (ROE) | 0% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | -35.21% |
| Revenue Per Employee | $368,916.26 |
| Profits Per Employee | $-212,827.59 |
| Employee Count | 203 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -15.76% in the last 52 weeks. The beta is 2.07, so Neuronetics's price volatility has been higher than the market average.
| Beta | 2.07 |
| 52-Week Price Change | -15.76% |
| 50-Day Moving Average | 3.96 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 43.54 |
| Average Volume (20 Days) | 1.58M |
Income Statement
In the last 12 months, Neuronetics had revenue of 74.89M and earned -43.2M in profits. Earnings per share was -1.37.
| Revenue | 74.89M |
| Gross Profit | 54.16M |
| Operating Income | -34.04M |
| Net Income | -43.2M |
| EBITDA | -34.04M |
| EBIT | -34.04M |
| Earnings Per Share (EPS) | -1.37 |
Balance Sheet
The company has 59.68M in cash and 62.47M in debt, giving a net cash position of -2.8M.
| Cash & Cash Equivalents | 59.68M |
| Total Debt | 62.47M |
| Net Cash | -2.8M |
| Retained Earnings | -376.08M |
| Total Assets | 133.45M |
| Working Capital | 26.63M |
Cash Flow
In the last 12 months, operating cash flow was -31M and capital expenditures -1.47M, giving a free cash flow of -32.46M.
| Operating Cash Flow | -31M |
| Capital Expenditures | -1.47M |
| Free Cash Flow | -32.46M |
| FCF Per Share | -1.03 |
Margins
Gross margin is 72.32%, with operating and profit margins of -45.45% and -57.69%.
| Gross Margin | 72.32% |
| Operating Margin | -45.45% |
| Pretax Margin | -57.69% |
| Profit Margin | -57.69% |
| EBITDA Margin | -45.45% |
| EBIT Margin | -45.45% |
| FCF Margin | -43.35% |
Dividends & Yields
STIM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -34.16% |
| FCF Yield | -12.71% |
Analyst Forecast
The average price target for STIM is $7, which is 74.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 74.6% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -3.54 |
| Piotroski F-Score | 3 |